Thursday, October 22, 2009

GBP Health / Biotech News 10-22-2009

Since August, 2005, this news digest has been a complimentary service of GBP Capital, a private equity firm investing in early to mid-stage life science companies. See www.gbpcap.com. The digest is published two to four days a week. If you have colleagues who would be interested in receiving this digest by email, they can be added to the list at: http://www.gbpcap.com/ <http://www.gbpcap.com/> . Also, the complete history of the entire content of all news articles in our digests since August, 2005 is searchable with Google's enterprise search engine at the same site.


Source - EurekAlert – Biology:


Public Release: 21-Oct-2009
Nature
New research shows how mobile DNA survives -- and thrives -- in plants, animals <http://www.eurekalert.org/pub_releases/2009-10/uog-nrs101909.php>
Bits of movable DNA called transposable elements or TEs fill up the genomes of plants and animals, but it has remained unclear how a genome can survive a rapid burst of hundreds, even thousands of new TE insertions. Now, for the first time, research led by plant biologists at the University of Georgia have documented the impact of such a burst in a rice strain that is accumulating more than 40 new TE insertions per plant per generation of an element called mPing.
Contact: Phil Williams
phil@franklin.uga.edu
706-542-8501
University of Georgia <http://www.uga.edu>


Public Release: 21-Oct-2009
Nature
Single-stranded DNA-binding protein is dynamic, critical to DNA repair <http://www.eurekalert.org/pub_releases/2009-10/uoia-sdp102109.php>
Researchers report that a single-stranded DNA-binding protein, once thought to be a static player among the many molecules that interact with DNA, actually moves back and forth along single-stranded DNA, gradually allowing other proteins to repair, recombine or replicate the strands.
National Science Foundation, Howard Hughes Medical Institute, National Institutes of Health
Contact: Diana Yates
diya@illinois.edu
217-333-5802
University of Illinois at Urbana-Champaign <http://www.uiuc.edu>


Public Release: 21-Oct-2009
Journal of Vascular and Interventional Radiology
Lifestyle changes remain important in fighting peripheral arterial disease <http://www.eurekalert.org/pub_releases/2009-10/soir-lcr102109.php>
Modifying the risk of peripheral arterial disease (or PAD) -- with healthy lifestyle changes -- remains vital to one's health, note researchers in a recent issue of the Journal of Vascular and Interventional Radiology. And while PAD can progress and worsen over time, there is not enough evidence yet to advocate minimally invasive treatment in patients who have had a narrowing or blockage of a leg artery but showing no signs or symptoms of the disease.
Contact: Maryann Verrillo
mverrillo@sirweb.org
703-460-5572
Society of Interventional Radiology <http://www.sirweb.org/>


Public Release: 21-Oct-2009
Nature
Researchers exploit genetic 'co-dependence' to kill treatment-resistant tumor cells <http://www.eurekalert.org/pub_releases/2009-10/dci-reg101909.php>
Cancer cells fueled by the mutant KRAS oncogene, which makes them notoriously difficult to treat, can be killed by blocking a more vulnerable genetic partner of KRAS, report scientists at the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT. By targeting the second, more easily inhibited "co-dependent" gene, TBK, the strategy bypasses the so far unfruitful head-on assault against the highly resistant KRAS gene.
NIH/National Cancer Institute
Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute <http://www.dfci.harvard.edu>


Public Release: 21-Oct-2009
Nature
Study shows how normal cells influence tumor growth <http://www.eurekalert.org/pub_releases/2009-10/osum-ssh101509.php>
A new study led by Ohio State University cancer researchers shows for the first time that the loss of a gene called PTEN from a type of normal cell in breast tumors can dramatically change the environment within the tumor in ways that foster the tumor's growth.
NIH/National Cancer Institute, Komen Breast Cancer Foundation, Evelyn Simmers Charitable Trust, Terry Fox New Frontiers Group Grant, Natural Science and Engineering Research Council of Canada
Contact: Darrell E. Ward
darrell.ward@osumc.edu
614-293-3737
Ohio State University Medical Center <http://www.osumedcenter.edu>


Public Release: 20-Oct-2009
Growing cartilage from stem cells <http://www.news.ucdavis.edu/search/news_detail.lasso?id=9281>
Damaged knee joints might one day be repaired with cartilage grown from stem cells in a laboratory.
Contact: Andy Fell
ahfell@ucdavis.edu
530-752-4533
University of California - Davis <http://www.ucdavis.edu>


Public Release: 18-Oct-2009
Nature Methods
Fate Therapeutics announces creation of small molecule platform for commercial-scale reprogramming <http://www.eurekalert.org/pub_releases/2009-10/mbci-fta101509.php>
Fate Therapeutics announced today the generation of human induced-pluripotent stem cells using a combination of small molecules that significantly improves the speed and efficiency of reprogramming. The discoveries, which were made by Sheng Ding, Ph.D., under a research collaboration between Fate Therapeutics and the Scripps Research Institute, represent a more than 200-fold improvement in reprogramming efficiency and reduce the reprogramming period to two weeks as compared to methods using only the four reprogramming factors.
Fate Therapeutics
Contact: Cory Tromblee
ctromblee@macbiocom.com
617-571-7220
MacDougall Biomedical Communications, Inc.


Public Release: 18-Oct-2009
Nature Materials
Small mechanical forces have big impact on embryonic stem cells <http://www.eurekalert.org/pub_releases/2009-10/uoia-smf101409.php>
Applying a small mechanical force to embryonic stem cells could be a new way of coaxing them into a specific direction of differentiation, researchers at the University of Illinois report. Applications for force-directed cell differentiation include therapeutic cloning and regenerative medicine.
National Institutes of Health, US Department of Agriculture, University of Illinois
Contact: James E. Kloeppel
kloeppel@illinois.edu
217-244-1073
University of Illinois at Urbana-Champaign <http://www.uiuc.edu>


Source - Science Daily:

Please note: Due to the format restrictions of Science Daily articles, you must click on the URL (web address) below the article summary, rather than the article title.


Alzheimer's Researchers Find High Protein Diet Shrinks Brain <http://www.sciencedaily.com/releases/2009/10/091020192206.htm>
One of the many reasons to pick a low-calorie and low-fat diet is that host of epidemiological studies have suggested that such a diet ...
http://www.sciencedaily.com/releases/2009/10/091020192206.htm

Blood Clots In Lungs Might Not Always Originate In Deep Veins Of Legs And Pelvis In Trauma Patients <http://www.sciencedaily.com/releases/2009/10/091019172329.htm>
October 21, 2009
— Few trauma patients who develop potentially deadly blood clots in the lungs (pulmonary embolism) also have clots in the deep veins of their pelvis and legs (deep venous thrombosis), challenging ...
http://www.sciencedaily.com/releases/2009/10/091019172329.htm

Aggressive Microdermabrasion Induces Wound-healing Response In Aging Skin <http://www.sciencedaily.com/releases/2009/10/091019172107.htm>
October 21, 2009
— Microdermabrasion using a coarse diamond-studded instrument appears to induce molecular changes in the skin of older adults that mimic the way skin is remodeled during the wound healing process, ...
http://www.sciencedaily.com/releases/2009/10/091019172107.htm

Research Shows Treating HIV-AIDS With Interleukin-2 Is Ineffective <http://www.sciencedaily.com/releases/2009/10/091015171457.htm>
October 21, 2009
— An international research team has demonstrated that treating HIV-AIDS with interleukin-2 is ineffective. As a result, the researchers recommend that clinical trials on this compound be ...
http://www.sciencedaily.com/releases/2009/10/091015171457.htm

Melanoma Treatment Options One Step Closer <http://www.sciencedaily.com/releases/2009/10/091020122534.htm>
October 20, 2009
— A targeted chemotherapy for the treatment of skin cancer is one step closer, after researchers successfully synthesized a natural substance that shows exceptional potential to specifically treat this ...
http://www.sciencedaily.com/releases/2009/10/091020122534.htm

Detecting The Undetectable In Prostate Cancer Screening <http://www.sciencedaily.com/releases/2009/10/091019162927.htm>
October 20, 2009
— Researchers, using an extremely sensitive tool based on nanotechnology, have detected previously undetectable levels of prostate-specific antigen (PSA) in patients who have undergone radical ...
http://www.sciencedaily.com/releases/2009/10/091019162927.htm

Added Oxygen During Stroke Reduces Brain Tissue Damage <http://www.sciencedaily.com/releases/2009/10/091019172333.htm>
October 20, 2009
— Scientists have countered findings of previous clinical trials by showing that giving supplemental oxygen to animals during a stroke can reduce damage to brain tissue surrounding the clot. The timing ...
http://www.sciencedaily.com/releases/2009/10/091019172333.htm

Studying Cancer In Pet Dogs To Find New Treatments For Human Patients <http://www.sciencedaily.com/releases/2009/10/091012225543.htm>
October 20, 2009
— Scientists say that studying pet dogs with cancer could yield valuable information on how to diagnose and treat human ...
http://www.sciencedaily.com/releases/2009/10/091012225543.htm

Dementia As A Terminal Illness: Understanding Clinical Course Of Disease Leads To Better End-of-life Care <http://www.sciencedaily.com/releases/2009/10/091014174009.htm>
October 20, 2009
— The clinical course of advanced dementia, including uncomfortable symptoms such as pain and high mortality, is similar to that experienced by patients of other terminal conditions, according to ...
http://www.sciencedaily.com/releases/2009/10/091014174009.htm

Unusual Metals Could Forge New Cancer Drug <http://www.sciencedaily.com/releases/2009/10/091019123107.htm>
October 19, 2009
— Drugs made using unusual metals could form an effective treatment against colon and ovarian cancer, including cancerous cells that have developed immunity to other drugs, according to new ...
http://www.sciencedaily.com/releases/2009/10/091019123107.htm

Small Mechanical Forces Have Big Impact On Embryonic Stem Cells <http://www.sciencedaily.com/releases/2009/10/091018141601.htm>
October 19, 2009
— Applying a small mechanical force to embryonic stem cells could be a new way of coaxing them into a specific direction of differentiation, researchers report. Applications for force-directed cell ...
http://www.sciencedaily.com/releases/2009/10/091018141601.htm

Process That Determines Fate Of White Blood Cells Uncovered <http://www.sciencedaily.com/releases/2009/10/091015123550.htm>
October 19, 2009
— Researchers describe how a protein called Id3 coaxes blood progenitor cells in the thymus into becoming gamma-delta T cells. Gamma-delta T cells represent only 5 percent of T cells, yet researchers ...
http://www.sciencedaily.com/releases/2009/10/091015123550.htm

Resident Physicians Seldom Trained In Skin Cancer Examination <http://www.sciencedaily.com/releases/2009/10/091019172109.htm>
October 19, 2009
— Many resident physicians are not trained in skin cancer examinations, nor have they ever observed or practiced the procedure, according to a new ...
http://www.sciencedaily.com/releases/2009/10/091019172109.htm

Bioengineering Of Nerve-muscle Connection Could Improve Hand Use For Wounded Soldiers <http://www.sciencedaily.com/releases/2009/10/091014122043.htm>
October 17, 2009
— Prosthetic hand devices used by wounded soldiers have limited motor control and no sensory feedback. But a bioengineered interface, made of muscle cells and a nano-sized polymer, could go a long way ...
http://www.sciencedaily.com/releases/2009/10/091014122043.htm




Source - Health Day:
Health Highlights: Oct. 21, 2009 <http://www.healthday.com/Article.asp?AID=632222>
  • Swine Flu Vaccine Production Behind Schedule
  • CDC Panel Recommends HPV Vaccine Cervarix
  • Check Commercial Drivers, Ship Pilots for Sleep Apnea: NTSB
  • Most Owners Would Perform CPR on Pets: Survey
  • Samsung Fined for Laptop Pesticide Claims: EPA
  • FDA Cracks Down on Misleading Food Labels
  • Sperm Donor Passed Heart Defect to Children
  • U.S. Med School Enrollment Up Again: Report
American Cancer Society Stands By Cancer Screening Guidelines
Group has no plans to rethink testing for breast, prostate tumors, contrary to published report.

Gene Behind Gaucher Disease a Player in Parkinson's <http://www.healthday.com/Article.asp?AID=632199>
Finding from worldwide study could one day lead to new treatments

Worldwide Vaccine Availability Reaches All-Time High: Report <http://www.healthday.com/Article.asp?AID=632185>
Experts urge international community to continue to push for progress

Clinical Trials Update: Oct. 21, 2009 <http://www.healthday.com/Article.asp?AID=632220>
  • Migraine
  • Chronic Low Back Pain
  • Parkinson's Disease
Clinical Trials Update: Oct. 20, 2009 <http://www.healthday.com/Article.asp?AID=632177>
  • Depression
  • Gout
  • Fibromyalgia
Clinical Trials Update: Oct. 19, 2009 <http://www.healthday.com/Article.asp?AID=632127>
  • High Cholesterol
  • Hepatitis C
  • Metastatic Colorectal Cancer - PEAK Study


Source - Yahoo Biotech News:

Amgen Beats, Raises Guidance <http://us.rd.yahoo.com/finance/industry/news/mostpop/*http:/biz.yahoo.com/zacks/091022/26258.html?.v=1> - Zacks.com - 1 hour, 25 minutes ago
U.S. sales increased 5%, primarily due to an increase in demand which was driven by an increase in units sold and price increases. International sales fell 7% to $313 million.

FDA delays ruling on Acorda's MS drug until Jan. <http://us.rd.yahoo.com/finance/industry/news/mostpop/*http:/biz.yahoo.com/ap/091022/us_acorda_therapeutics_fda_delay.html?.v=1> - AP - Thu 6:38 am ET
Acorda Therapeutics Inc. said Thursday the Food and Drug Administration delayed a ruling on its multiple sclerosis drug candidate Fampridine-SR by three months.


Source - Google Health News:

GLOBAL: State of world's vaccines and immunization <http://www.google.com/url?sa=X&q=http://www.irinnews.org/Report.aspx%3FReportId%3D86679&ct=ga&cd=NTgehl8Tk4g&usg=AFQjCNHVwYvwcN3c_zgJ4jdbrbRlS_ODqA>
IRINnews.org
Two H5N1 flu vaccines have been developed in the US and Europe. Six vaccine manufacturers in developing countries have started H5N1 vaccine development as ...

Italy obtains European funding for gene therapy <http://www.google.com/url?sa=X&q=http://news.xinhuanet.com/english/2009-10/22/content_12294192.htm&ct=ga&cd=6zAzazTZuLw&usg=AFQjCNFOv1gjD06ObWGLmdwciGMipKxUdw>
Xinhua
ROME, Oct. 21 (Xinhua) -- An Italian research group on Wednesday obtained European funding for a new gene therapy aimed at preventing the most common form ...

Approval for H1N1 vaccine expected this week <http://www.google.com/url?sa=X&q=http://www.theglobeandmail.com/news/national/approval-for-h1n1-vaccine-expected-this-week/article1328738/&ct=ga&cd=qRp4ArOHfW0&usg=AFQjCNHEJ_IubgQObWifP-BaLKtP8VW2rw>
Globe and Mail
But components of the vaccine have been proven to be safe: The adjuvant has been tested on thousands with the H5N1 avian flu drug, and the antigen has been ...

'Spectacular results' hailed for muscular dystrophy drug <http://www.google.com/url?sa=X&q=http://www.timesonline.co.uk/tol/news/science/medicine/article6882646.ece&ct=ga&cd=A0oDrPSiVVI&usg=AFQjCNGu3xVo85eka0pulg_RL81OH85yeQ>
Times Online
A gene therapy for the most severe type of muscular dystrophy has achieved spectacular results in animal tests, opening a powerful new approach to treating ...

We need to learn more about ProSavin Phase I/II Trial in Parkinson's disease <http://www.google.com/url?sa=X&q=http://www.glgroup.com/News/We-need-to-learn-more-about-ProSavin-Phase-I-II-Trial-in-Parkinsons-disease-44292.html&ct=ga&cd=A0oDrPSiVVI&usg=AFQjCNFfKS2AlQ23arYpsHuaLK2eMY4YcQ>
Gerson Lehrman Group
The expanding experimental study should be addressed to determine how this gene therapy acts on the selective population of neurons in vivo and how the ...

Scientists using gene therapy to treat Parkinson's disease <http://www.google.com/url?sa=X&q=http://www.newspostonline.com/science/scientists-using-gene-therapy-to-treat-parkinsons-disease-2009101871809&ct=ga&cd=RmxuNedILHM&usg=AFQjCNH7ATTU4KPedoKuIz7rzFppcM4qzg>
Newspost Online
Scientists from French Atomic Energy Commission's Institute of Biomedical Imaging in Orsay are using gene therapy to treat Parkinson's disease. ...



Source - Medical News Today:


High Protein Diet May Shrink Brain Say Alzheimer's Researchers <
http://www.medicalnewstoday.com/articles/168211.php>
Researchers observing the effects of various diets on the brains of genetically engineered mice bred for studying Alzheimer's disease <
http://www.medicalnewstoday.com/articles/159442.php> found quite unexpectedly that mice fed a high protein, low carbohydrate <http://www.medicalnewstoday.com/articles/161547.php> diet, developed brains that were five per cent lighter than those of mice fed other diets. The study was the work of lead author, Sam Gandy, a professor at The Mount Sinai School of Medicine in New York City and a neurologist at the James J Peters Veterans Affairs Medical Center in the Bronx NY, and colleagues from research centers in the US, Canada, Australia and the UK. The study is published this week in BioMed Central's open access journal Molecular Neurodegeneration.
http://www.medicalnewstoday.com/articles/168211.php

StemCells, Inc.'s Neural Stem Cells Show Promise For Treating Age-Related Macular Degeneration <
http://www.medicalnewstoday.com/articles/168011.php>
StemCells, Inc. (NASDAQ:STEM) announced new preclinical data showing that its human neural stem cells <
http://www.medicalnewstoday.com/info/stem_cell/whatarestemcells.php> protect cone photoreceptors (cones) in the eye from progressive degeneration and preserve visual function long term. Cones are light sensing cells that are highly concentrated within the macula of the human eye, and the ability to protect these cells suggests a promising approach to treating age-related macular degeneration <http://www.medicalnewstoday.com/articles/152105.php> (AMD), the leading cause of vision loss and blindness in people over the age of 55. These important findings were presented today in Chicago, Illinois at the Society for Neuroscience 2009 Annual Meeting, one of the leading forums for neuroscientists from around the world to present and discuss cutting-edge research in the field. "We have long recognized that a number of eye disorders may be suitable candidates for stem cell-based therapies," stated Stephen Huhn, MD, FACS, FAAP, vice president and head of the CNS program at StemCells, Inc. "The demonstrated ability of our human neural stem cells to preserve cones is very meaningful, because it is the progressive deterioration of these specific cells that ultimately results in vision loss in AMD. These data support our hypothesis that our neural stem cells may provide neuroprotection to existing cells, and it is our hope that we will be able to replicate these promising results in the clinic."
http://www.medicalnewstoday.com/articles/168011.php

Neural Stopwatch Found In The Brain <
http://www.medicalnewstoday.com/articles/168009.php>
What's New: MIT researchers have identified populations of neurons that code time with extreme precision in the primate brain. These neurons are found in two interconnected brain regions, the prefrontal cortex and the striatum, both of which are known to play critical roles in learning, movement, and thought control. Why it matters: The timing of individual actions, whether we are speaking, driving a car, or playing the piano, require very precise control. Although our daily life is extremely dependent on this remarkable capability, surprisingly little has been known about how time is represented in the activity of brain cells. The discovery made by MIT neuroscientists is an important step toward answering this fundamental question.
http://www.medicalnewstoday.com/articles/168009.php
-


Source - MIT's Technology Review:


Massive Gene Database Planned in California <
http://www.technologyreview.com/biomedicine/23777/>
http://www.technologyreview.com/biomedicine/23777/

Blood Test Offers More Accurate Picture of Health <http://www.technologyreview.com/business/23776/>
http://www.technologyreview.com/business/23776/

Decoding the Brain with Light <
http://www.technologyreview.com/biomedicine/23767/>
http://www.technologyreview.com/biomedicine/23767/

Friday, October 16, 2009

GBP Health / Biotech News 10-16-2009

Since August, 2005, this news digest has been a complimentary service of GBP Capital, a private equity firm investing in early to mid-stage life science companies. See www.gbpcap.com. The digest is published two to four days a week. If you have colleagues who would be interested in receiving this digest by email, they can be added to the list at: http://www.gbpcap.com/ <http://www.gbpcap.com/> . Also, the complete history of the entire content of all news articles in our digests since August, 2005 is searchable with Google's enterprise search engine at the same site.


Source - EurekAlert – Biology:



Public Release: 16-Oct-2009
New findings on the formation of body pigment <http://ki.se/ki/jsp/polopoly.jsp?l=en&d=130&a=85186&newsdep=130>
The skin's pigment cells can be formed from completely different cells than has hitherto been thought, a new study from the Swedish medical university Karolinska Institutet shows. The results, which are published in the journal Cell, also mean the discovery of a new kind of stem cell.
Contact: Press Officer Katarina Sternudd
katarina.sternudd@ki.se <mailto:katarina.sternudd@ki.se>
46-852-483-895
Karolinska Institutet <http://info.ki.se/ki>


Public Release: 16-Oct-2009
'Spaghetti' scaffolding could help grow skin in labs <http://www.eurekalert.org/pub_releases/2009-10/babs-sc101609.php>
Scientists are developing new scaffolding technology which could be used to grow tissues such as skin, nerves and cartilage using 3D spaghetti-like structures. Their research is highlighted in the latest issue of Business, the quarterly highlights magazine of the Biotechnology and Biological Sciences Research Council.
Contact: Tracey Jewitt
press.office@bbsrc.ac.uk <mailto:press.office@bbsrc.ac.uk>
01-793-414-694
Biotechnology and Biological Sciences Research Council <http://www.bbsrc.ac.uk/>


Public Release: 16-Oct-2009
Journal of Experimental Biology
Super sticky barnacle glue cures like blood clots <http://www.eurekalert.org/pub_releases/2009-10/tcob-ssb100709.php>
Barnacles are a major problem for the shipping industry. Working out how they stick to boat hulls is of major economic importance. On Oct. 16, 2009, Dan Rittschof from Duke University publishes his amazing discovery that barnacle glue cures in the same way that blood clots. "Barnacle glue polymerization is a specialized form of wound healing," says Rittschof.
Office of Naval Research
Contact: Kathryn Knight
kathryn@biologists.com <mailto:kathryn@biologists.com>
44-122-342-5525
The Company of Biologists <http://www.biologists.com/>


Public Release: 15-Oct-2009
Bug barcode readers hold out promise of universal vaccines <http://www.bbsrc.ac.uk/media/releases/2009/091015_bug_barcode_readers_promise_universal_vaccines.html>
Veterinary scientists have made a discovery that promises to deliver a new approach to fast development of cheap vaccines that are effective in all mammals -- not just humans or another particular species.
Biotechnology and Biological Sciences Research Council, Scottish Executive, Pfizer Ltd.
Contact: Tracey Jewitt
press.office@bbsrc.ac.uk <mailto:press.office@bbsrc.ac.uk>
01-793-414-694
Biotechnology and Biological Sciences Research Council <http://www.bbsrc.ac.uk/>


Public Release: 15-Oct-2009
American Journal of Human Genetics
Gene mutation may reveal clues for treating lung diseases <http://mednews.wustl.edu/news/page/normal/14880.html>
A genetic mutation found in four children born with multiple abnormalities may provide insight into potential treatments for newborn lung distress and chronic obstructive pulmonary disease.
National Institutes of Health, March of Dimes, Phillip Morris USA Inc., Canadian Institutes of Health Research
Contact: Beth Miller
millerbe@wustl.edu <mailto:millerbe@wustl.edu>
314-286-0119
Washington University School of Medicine <http://www.medicine.wustl.edu/>


Public Release: 15-Oct-2009
Retrovirology
Xenotropic murine leukemia virus-related virus may not be associated with human prostate cancer <http://www.eurekalert.org/pub_releases/2009-10/bc-xml101409.php>
The xenotropic murine leukemia virus-related virus which has previously been linked to prostate cancer has been found to have a dramatically lower prevalence among German prostate cancer patients, if any. Contrary to some reports, which have found XMRV in 40 percent of cases in patients in the US with familial prostate cancer, research published today in BioMed Central's open access journal Retrovirology has found no link between the two conditions in a large study of German prostate cancer patients.
Contact: Charlotte Webber
charlotte.webber@biomedcentral.com <mailto:charlotte.webber@biomedcentral.com>
44-020-319-22129
BioMed Central <http://www.biomedcentral.com/>


Public Release: 15-Oct-2009
Science Express
Researchers identify promising therapeutic target for central nervous system injuries <http://www.eurekalert.org/pub_releases/2009-10/hms-rip101209.php>
Researchers have identified a promising therapeutic target for central nervous system injuries. Following such an injury, scar tissue releases molecules that keep neurons from passing, so they cannot restore motor and sensory function. Researchers have identified where these inhibitory molecules bind to the surface of neurons, exposing a novel therapeutic target.
National Institutes of Health
Contact: Alyssa Kneller
communications@hms.harvard.edu <mailto:communications@hms.harvard.edu>
617-432-0442
Harvard Medical School <http://hms.harvard.edu/>


Public Release: 15-Oct-2009
Cell
Discovery of enzyme structure points way to creating less toxic anti-HIV drugs <http://www.eurekalert.org/pub_releases/2009-10/uota-doe101209.php>
By discovering the atomic structure of a key human enzyme, researchers at the University of Texas at Austin have pointed the way toward designing anti-HIV drugs with far less toxic side effects.
National Institutes of Health, Welch Foundation
Contact: Whitney Yin
whitney.yin@mail.utexas.edu <mailto:whitney.yin@mail.utexas.edu>
512-471-5583
University of Texas at Austin <http://www.utexas.edu/>



Source - Science Daily:
Please note: Due to the format restrictions of Science Daily articles, you must click on the URL (web address) below the article summary, rather than the article title.


Skin Cells May Provide Early Warning For Cancer Risk Elsewhere In Body <http://www.sciencedaily.com/releases/2009/10/091015163555.htm>
October 16, 2009
— If susceptibility to cancer is the result of inherited genetic mutations, then DNA in all the body's cells should have these mutations. A cell biologist argues that, since skin cells are easy to ...
http://www.sciencedaily.com/releases/2009/10/091015163555.htm <http://www.sciencedaily.com/releases/2009/10/091015163555.htm>

Promising Therapeutic Target For Central Nervous System Injuries Identified <http://www.sciencedaily.com/releases/2009/10/091015141458.htm>
October 16, 2009
— Researchers have identified a promising therapeutic target for central nervous system injuries. Following such an injury, scar tissue releases molecules that keep neurons from passing, so they cannot ...
http://www.sciencedaily.com/releases/2009/10/091015141458.htm <http://www.sciencedaily.com/releases/2009/10/091015141458.htm>

Skin's Pigment Cells Can Be Formed From Completely Different Cells Than Previously Thought <http://www.sciencedaily.com/releases/2009/10/091016121825.htm>
October 16, 2009
— The skin's pigment cells can be formed from completely different cells than has hitherto been thought, a new study from Sweden shows. The results also mean the discovery of a new kind of stem ...
http://www.sciencedaily.com/releases/2009/10/091016121825.htm <http://www.sciencedaily.com/releases/2009/10/091016121825.htm>

Some Color Shades Offer Better Protection Against Sun’s Ultraviolet Rays <http://www.sciencedaily.com/releases/2009/10/091014130708.htm>
October 15, 2009
— Economy-minded consumers who want protection from the sun's harmful ultraviolet rays -- but rather not pay premium prices for sun-protective clothing -- should think blue and red, rather than yellow. ...
http://www.sciencedaily.com/releases/2009/10/091014130708.htm <http://www.sciencedaily.com/releases/2009/10/091014130708.htm>

Which Is Promising As Therapeutic Targets In Patients With Biliary Tract Cancer? EGFR Or HER2? <http://www.sciencedaily.com/releases/2009/10/091016093916.htm>
October 16, 2009
— A research team from Germany analyzed the pathogenetic role and potential clinical usefulness of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor 2 (HER2) in ...
http://www.sciencedaily.com/releases/2009/10/091016093916.htm <http://www.sciencedaily.com/releases/2009/10/091016093916.htm>

Scientists Remove Amyloid Plaques From Brains Of Live Animals With Alzheimer's Disease <http://www.sciencedaily.com/releases/2009/10/091015091602.htm>
October 15, 2009
— A breakthrough discovery in mice may lead to a new treatment for Alzheimer's disease that actually removes amyloid plaques -- considered a hallmark of the disease -- from patients' brains. This ...
http://www.sciencedaily.com/releases/2009/10/091015091602.htm <http://www.sciencedaily.com/releases/2009/10/091015091602.htm>

Loss Of Tumor-suppressor And DNA-maintenance Proteins Causes Tissue Demise <http://www.sciencedaily.com/releases/2009/10/091015171453.htm>
October 15, 2009
— A new study demonstrates that loss of the tumor-suppressor protein p53, coupled with elimination of the DNA-maintenance protein ATR, severely disrupts tissue maintenance in mice. As a result, tissues ...
http://www.sciencedaily.com/releases/2009/10/091015171453.htm <http://www.sciencedaily.com/releases/2009/10/091015171453.htm>

Stem Cells Offer New Hope For Kidney Disease Patients <http://www.sciencedaily.com/releases/2009/10/091015171451.htm>
October 15, 2009
— Several cell-based therapy approaches could provide new treatments for patients with Alport syndrome, according to a new ...
http://www.sciencedaily.com/releases/2009/10/091015171451.htm <http://www.sciencedaily.com/releases/2009/10/091015171451.htm>

Ultra-low Power Actuator Suitable For In-vivo Biomedical Applications <http://www.sciencedaily.com/releases/2009/10/091006104502.htm>
October 14, 2009
— Researchers have developed an actuator that runs on ultra-low power and that is watertight. This innovative combination of characteristics makes the actuator especially suited for use in in-vivo ...
http://www.sciencedaily.com/releases/2009/10/091006104502.htm <http://www.sciencedaily.com/releases/2009/10/091006104502.htm>



Source - Health Day:


Health Highlights: Oct. 16, 2009 <http://www.healthday.com/Article.asp?AID=632063>
  • FDA Approves Cervarix Vaccine
  • Placebo Effect Detected in Spinal Cord
  • Marijuana Used by Nearly 4 Percent of Adults Worldwide: Study
  • Special Bracelets Don't Help Arthritis Patients
New FDA Study Seeks Feedback on Lasik Surgery
Warnings issued to 17 centers for lax reporting of procedure-related adverse events.

Docs May Be Overdoing Some Invasive Procedures <http://www.healthday.com/Article.asp?AID=631948>
For certain patients with renal artery stenosis, medication may be enough, researchers say
Clinical Trials Update: Oct. 16, 2009 <http://www.healthday.com/Article.asp?AID=632064>
  • Healthy Volunteers (Ages 18+)
  • Alzheimer's Disease
  • GERD (Acid Reflux)
A Drug to Cure Spinal Cord Injuries? <http://www.healthday.com/Article.asp?AID=631946>
That idea is not so far-fetched, say scientists who now have possible targets for therapy


Source - Yahoo Biotech News:


Targacept hits annual high on depression drug data <http://us.rd.yahoo.com/finance/industry/news/mostpop/*http:/biz.yahoo.com/ap/091016/us_targacept_depression_drug.html?.v=1> - AP - Fri 10:57 am ET
Shares of Targacept Inc. surged Friday after the company provided full results from a successful mid-stage study of its depression drug candidate TC-5214.

Adipose-Derived Stem and Regenerative Cells Show Potential in First-in-Man Treatment of Stress Urinary Incontinence <http://us.rd.yahoo.com/finance/industry/news/mostpop/*http:/biz.yahoo.com/bw/091015/20091015006463.html?.v=1> - Business Wire - Thu 9:59 pm ET
SAN DIEGO----Cytori was informed that stem and regenerative cells from a patient’s own fat tissue were used to treat stress urinary incontinence as part of an investigator-initiated five patient pilot study in Japan.

China's Swine Flu Darling Is No One Trick Pony <http://us.rd.yahoo.com/finance/industry/news/mostpop/*http:/biz.yahoo.com/indie/091014/2428_id.html?.v=1> - Indie Research - Wed Oct 14
Beijing-based vaccine company Sinovac Biotech has, like many of its peers, experienced its share of pops and drops riding waves of demand on the global epidemic rollercoaster.


Source - Google Health News:


Japanese NIH Research Reaffirms and Expands Pandemic Flu Protection by Ampligen(R) <http://www.google.com/url?sa=X&q=http://www.globenewswire.com/newsroom/news.html%3Fd%3D175541&ct=ga&cd=npFO5fNrwMI&usg=AFQjCNEbfCq0Y1M8jugw8hh6VzWj55ChbA>
GlobeNewsWire (press release)
Dr. Hasegawa provided an overview of intranasal pandemic flu vaccine ( H5N1) and nasal immunity mechanisms. The new data consist of both expanded clinical ...

Sales of GlaxoSmithKline's Relenza Likely to Increase During the A/H1N1 2009 <http://www.google.com/url?sa=X&q=http://www.prnewswire.com/news-releases/sales-of-glaxosmithklines-relenza-likely-to-increase-during-the-ah1n1-2009-pandemic-as-tamiflu-resistant-strains-of-the-virus-spread-64352097.html&ct=ga&cd=npFO5fNrwMI&am>
PR Newswire (press release)
"Relenza did not enjoy the success seen by Tamiflu during the H5N1 influenza scare, also known as the avian flu, mostly because it is an inhalable product, ...

Gene Therapy Method Slows Tumor Growth in Mice <http://www.google.com/url?sa=X&q=http://media-newswire.com/release_1102875.html&ct=ga&cd=7Z96XvX-d_k&usg=AFQjCNFY3pcPKtcN76LH70FK6OBAswUleg>
Media Newswire (press release)
... cells in the tumor tissue to die and slowed tumor growth significantly. The results of this study appeared online October 9, 2009, in Cancer Gene Therapy.

AMT's DMD treatment gains orphan status in Europe <http://www.google.com/url?sa=X&q=http://www.reuters.com/article/rbssHealthcareNews/idUSLD54527920091013&ct=ga&cd=_SjXUD9piOI&usg=AFQjCNFIdYsgsw1fwk5HgHiGtZUnd0FE5w>
Reuters
AS) said on Tuesday its gene therapy treatment for Duchenne muscular dystrophy has been granted orphan drug designation by the European Medicines Agency ...

A Gene Tweak Could Keep Heart Young <http://www.google.com/url?sa=X&q=http://www.usnews.com/articles/health/healthday/2009/10/12/a-gene-tweak-could-keep-heart-young.html&ct=ga&cd=_SjXUD9piOI&usg=AFQjCNFZFmZQQrWgBvkvEW6YoT4M6GCAnQ>
U.S. News & World Report
The gene plays an important role in both the aging and proliferation of cells, and research is aimed at developing gene therapy not only for heart disease ...

China is in the lead for a new cancer alternative treatment <http://www.google.com/url?sa=X&q=http://www.bestsyndication.com/%3Fq%3D20091014_china_cancer_treatments.htm&ct=ga&cd=c2zfzPGeQBM&usg=AFQjCNEMlNxsy8rlW6PBN28KWbitoRQabQ>
Best Syndication
Since the arrival of the world's first government-approved gene therapy for cancer drug in 2003, China has been propelled to the front of the pack in the ...

Long-term monkey tests back Oxford's gene therapy <http://www.google.com/url?sa=X&q=http://www.reuters.com/article/scienceNews/idUSTRE59D4DL20091014&ct=ga&cd=c2zfzPGeQBM&usg=AFQjCNHpx42lcOZSMwaZPbJhGivLVAMPNg>
Reuters
LONDON (Reuters) - Long-term tests on monkeys using Oxford BioMedica's gene therapy ProSavin suggest it can treat Parkinson's disease without causing the ...


Source - Medical News Today:


Inovio Biomedical Announces Initiation Of HIV Clinical Trial For DNA Vaccine Delivered Using Electroporation <http://www.medicalnewstoday.com/articles/167685.php>
Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, and the
HIV <http://www.medicalnewstoday.com/articles/17131.php> Vaccine Trials Network (HVTN) announced today the initiation of a phase I clinical study of Inovio's PENNVAX™-B preventive DNA vaccine delivered using its proprietary electroporation technology. The multi-center study will be conducted at several HVTN clinical sites under a protocol designated HVTN-080. The study will enroll healthy volunteers to assess the safety of and immune responses to this DNA-based vaccine delivered via in vivo electroporation. Inovio previously reported data from non-human primates demonstrating up to a 100-fold enhancement in immune responses resulting from the vaccine when delivered via in vivo electroporation compared to syringe injection without electroporation. PENNVAX™-B is currently in a clinical study, being conducted under the HVTN-070 protocol by the same group of collaborators, to test safety and immunogenicity of the vaccine delivered via intramuscular syringe injection without electroporation. The HVTN-080 follow-on study is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), an NIH agency.
http://www.medicalnewstoday.com/articles/167685.php <http://www.medicalnewstoday.com/articles/167685.php>

Trialing Major Weight Loss For Type 2 Diabetes In The Overweight <http://www.medicalnewstoday.com/articles/167532.php>
In the first trial of its kind in the world, researchers at Monash University's Centre for Obesity Research and Education (CORE) will examine the benefits of a gastric banding procedure on overweight people with Type 2
diabetes <http://www.medicalnewstoday.com/info/diabetes/whatisdiabetes.php> . Lead investigator Professor Paul O'Brien said until now gastric banding surgery was reserved for people who were obese - with a Body Mass Index (BMI) rating greater than 30.
http://www.medicalnewstoday.com/articles/167532.php <http://www.medicalnewstoday.com/articles/167532.php>

Medical Imaging Identifies Severe Case Of H1N1 And May Help Researchers Understand The Pathogenesis Of The Virus <http://www.medicalnewstoday.com/articles/167450.php>
Researchers at the National Institutes of Health (NIH) have found that imaging can now be used as a tool for identifying severe cases of
H1N1 <http://www.medicalnewstoday.com/articles/147720.php> and may play a key role in understanding the pathogenesis of the virus, possibly leading to earlier diagnoses of severe cases in the future, according to a study published online today in the American Journal of Roentgenology. The study will be published in the December issue of AJR. Imaging revealed a severe case of H1N1 after a patient had tested negative using a nasal swab rapid antigen test. Radiography (standard X -ray) showed peripheral lung opacities, and computed tomography (CT) revealed peripheral ground-glass opacities. Both findings raised suspicion of H1N1 and reports revealed that the patient later died from a severe case of H1N1.
http://www.medicalnewstoday.com/articles/167450.php <http://www.medicalnewstoday.com/articles/167450.php>

A New Scan For Lung Diseases <http://www.medicalnewstoday.com/articles/167376.php>
People with chronic lung disease and
asthma <http://www.medicalnewstoday.com/info/asthma/what-is-asthma.php> could soon be offered better treatment thanks to a new type of Magnetic Resonance Imaging (MRI) scan being pioneered at The University of Nottingham. A purpose-built MRI research unit has been established to study a range of respiratory diseases. The unit is based at the Queens Medical Centre and will allow doctors to virtually 'see inside' the lungs of patients using a new, specifically-adapted MRI scanner.
http://www.medicalnewstoday.com/articles/167376.php <http://www.medicalnewstoday.com/articles/167376.php>
-

Source - MIT's Technology Review:

Making Heart Muscle <http://www.technologyreview.com/biomedicine/23746/>
http://www.technologyreview.com/biomedicine/23746/ <http://www.technologyreview.com/biomedicine/23746/>

GBP Health / Biotech News 10-14-2009

Since August, 2005, this news digest has been a complimentary service of GBP Capital, a private equity firm investing in early to mid-stage life science companies. Please see www.gbpcap.com for more information. The digest is published two to four days a week. If you have colleagues who would be interested in receiving this digest, they can be added to the list at: www.gbpcap.com. To search the archive of all published digests please visit: www.gpbcap.com/ja/news/news-digest-archive.html



Source - EurekAlert Biology:


Public Release: 14-Oct-2009

Emerging Infectious Diseases

Earlier flu viruses provided some immunity to current H1N1 influenza, study shows

University of California, Davis, researchers studying the 2009 H1N1 influenza virus, formerly referred to as "swine flu," have identified a group of immunologically important sites on the virus that are also present in seasonal flu viruses that have been circulating for years. These molecular sites appear to result in some level of immunity to the new virus in people who were exposed to the earlier influenza viruses.

US Department of Homeland Security, UC Davis Center for California Food Animal Health


Contact: Patricia Bailey

pjbailey@ucdavis.edu

530-752-9843

University of California - Davis


Public Release: 14-Oct-2009

American College of Surgeons 95th Clinical Congress

Bioengineering of nerve-muscle connection could improve hand use for wounded soldiers

Prosthetic hand devices used by wounded soldiers have limited motor control and no sensory feedback. But a bioengineered interface, developed at the University of Michigan and made of muscle cells and a nano-sized polymer, could go a long way in creating prostheses that move like a normal hand. Animal studies show the interface may possibly restore a sense of touch.

US Department of Defense


Contact: Shantell M. Kirkendoll

smkirk@umich.edu

734-764-2220

University of Michigan Health System


Public Release: 14-Oct-2009

Nature

What drives our genes? Salk researchers map the first complete human epigenome

Although the human genome sequence faithfully lists (almost) every single DNA base of the roughly 3 billion bases that make up a human genome, it doesn't tell biologists much about how its function is regulated. Now, researchers at the Salk Institute provide the first detailed map of the human epigenome, the layer of genetic control beyond the regulation inherent in the sequence of the genes themselves.


Contact: Gina Kirchweger

kirchweger@salk.edu

858-453-410-01685

Salk Institute


Public Release: 13-Oct-2009

Proceedings of the National Academy of Sciences

New cancer gene discovered

A new cancer gene has been discovered by a research group at the Sahlgrenska Academy at the University of Gothenburg, Sweden. The gene causes an insidious form of glandular cancer usually in the head and neck and in women also in the breast. The discovery could lead to quicker and better diagnosis and more effective treatment.


Contact: Professor Goran Stenman

goran.stenman@llcr.med.gu.se

46-313-422-922

University of Gothenburg


Public Release: 12-Oct-2009

Nature Medicine

Magnetic nanotags spot cancer in mice earlier than methods now in clinical use

Searching for biomarkers that can warn of diseases such as cancer while they are still in their earliest stage is likely to become far easier thanks to an innovative biosensor chip developed by Stanford University researchers. The sensor is up to 1,000 times more sensitive than technologynow in clinical use, accurate regardless of which bodily fluid is being analyzed and can detect biomarker proteins over a concentration range three times broader than existing methods.

NIH/National Cancer Institute, National Science Foundation, Defense Threat Reduction Agency, Defense Advanced Research Projects Agency, US Department of Veterans Affairs, Canary Foundation, National Semiconductor Corporation.


Contact: Louis Bergeron

louisb3@stanford.edu

650-725-1944

Stanford University


Public Release: 11-Oct-2009

Nature Materials

New nanotech sensor developed with medical, chemistry applications

Researchers at Oregon State University and other institutions have developed a new "plasmonic nanorod metamaterial" using extraordinarily tiny rods of gold that will have important applications in medical, biological and chemical sensors.

National Science Foundation


Contact: Viktor Podolskiy

viktor.podolskiy@physics.oregonstate.edu

541-737-1702

Oregon State University



Source - Science Daily:


Please note: Due to the format restrictions of Science Daily articles, you must click on the URL (web address) below the article summary, rather than the article title.



New Cancer Gene Discovered

October 14, 2009 A new cancer gene has been discovered by researchers in Sweden. The gene causes an insidious form of glandular cancer usually in the head and neck and in women also in the breast. The discovery could ...

http://www.sciencedaily.com/releases/2009/10/091013105320.htm


Using RNAi-based Technique, Scientists Find New Tumor Suppressor Genes In Lymphoma

October 14, 2009 Researchers have uncovered a large, new cache of genes that act as built-in barriers against cancer. Known as tumor suppressors, the newly identified genes and the insight that they provide into ...

http://www.sciencedaily.com/releases/2009/10/091013110048.htm


Less Invasive Procedure For Repair Of Abdominal Aortic Aneurysm May Reduce Short-term Risk Of Death

October 14, 2009 Patients who received the less-invasive endovascular repair of an abdominal aortic aneurysm had a lower risk of death in the first 30 days after the procedure compared to patients who an open repair, ...

http://www.sciencedaily.com/releases/2009/10/091013112512.htm


Researchers Find Candidates For New HIV Drugs

October 14, 2009 Researchers have found compounds that show promise as novel drugs to treat HIV infection in the process of developing a method to assess the activity of a protein that plays an essential role in the ...


http://www.sciencedaily.com/releases/2009/10/091013112519.htm


A New Scan For Lung Diseases

October 14, 2009 People with chronic lung disease and asthma could soon be offered better treatment thanks to a new type of Magnetic Resonance Imaging (MRI) ...

http://www.sciencedaily.com/releases/2009/10/091013210000.htm


Bioluminescence Imaging Used For Eye Cancer Detection

October 14, 2009 At the moment, doctors rely on biopsy analysis to determine the progression of eye cancer. However, researchers now believe that a new technology, bioluminescence imaging, will allow doctors to ...

http://www.sciencedaily.com/releases/2009/10/091013112516.htm


Elderly Immune System Needs A Boost: Older Cancer Sufferers Need Treatments Tailored To Their Aging Immune Systems

October 14, 2009 Elderly cancer patients need a combination of treatments tailor-made to their specific needs to successfully combat the disease. A new review examines the effects of aging on the immune system and ...

http://www.sciencedaily.com/releases/2009/10/091008113301.htm


SCID Kids Leading Healthy, Normal Lives 25 Years After 'Bubble Boy'

October 13, 2009 Mention the words "bubble boy" and many will recall David Vetter, the kid with big eyes and a thick thatch of dark hair who died 25 years ago after spending almost the entire 12 years of his life in ...


http://www.sciencedaily.com/releases/2009/10/091013105815.htm


Loss Of Tumor Supressor Gene Essential To Transforming Benign Nerve Tumors Into Cancers

October 13, 2009 Researchers have shown for the first time that the loss or decreased expression of the tumor suppressor gene PTEN plays a central role in the malignant transformation of benign nerve tumors called ...

http://www.sciencedaily.com/releases/2009/10/091013105828.htm


Investment In Parkinson's Disease Data Bank Yields Potential Therapy

October 13, 2009 Individuals with Parkinson's disease who have higher levels of a metabolite called urate in their blood and in cerebrospinal fluid (CSF) have a slower rate of disease progression, according to a ...

http://www.sciencedaily.com/releases/2009/10/091012230532.htm


Blood Counts Are Clues To Human Disease

October 12, 2009 New research examines that most important and diverse of tissues -- blood -- for genetic markers important in health. Scientists have found 15 new genetic variants associated with diseases including ...

http://www.sciencedaily.com/releases/2009/10/091011184422.htm


New Findings About Brain Proteins Suggest Possible Way To Fight Alzheimer's

October 12, 2009 The action of a small protein that is a major villain in Alzheimer's disease can be counterbalanced with another brain protein, researchers have found in an animal ...

http://www.sciencedaily.com/releases/2009/10/091006122330.htm


Enhanced Stem Cells Promote Tissue Regeneration

October 11, 2009 Engineers have boosted stem cells' ability to regenerate vascular tissue (such as blood vessels) by equipping them with genes that produce extra growth factors (naturally occurring compounds that ...

http://www.sciencedaily.com/releases/2009/10/091005161120.htm



Source - Health Day:



Health Highlights: Oct. 14, 2009


U.N. Agencies Aim to Reduce Diarrhea Death Toll

Coma Patient Gives Birth to Healthy Baby

Women Cry More, Longer Than Men

Unsafe Abortions Kill 70,000 Women Each Year: Survey

More than One Billion People Hungry: U.N.

Stents Tested for Treatment of Erectile Dysfunction


Gene Therapy Shows Promise for Parkinson's

Treatment tested in monkeys addresses only motor issues, though, experts say


Study Suggests Link Between Cell Phones and Brain Tumors

Higher-quality data see danger from long-term use, new review finds


Clinical Trials Update: Oct. 14, 2009

Chronic Low Back Pain

Diverticulitis

High Blood Pressure (Hypertension)



Source - Yahoo Biotech News:


ZioPharm shares rise on positive study data - AP - Wed 12:37 pm ET

Shares of ZioPharm Oncology Inc. jumped Wednesday after the company said its developing cancer treatment Zymafos met a key midstage study goal.


US and Canada regulators approve Pfizer-Wyeth deal - AP - 1 hour, 3 minutes ago

Pfizer Inc.'s $68 billion purchase of Wyeth will close Thursday after antitrust regulators in the U.S. and Canada cleared the deal, which will make Pfizer the world's largest drugmaker by revenue.



Source - Google Health News:


US could potentially use controversial adjuvants in swine flu vaccine

San Jose Mercury News

"It was going to be avian flu an adjuvanted vaccine for H5N1 avian flu was approved in many countries, but the disease never spread person to person. ...


Research may help Parkinson's patients

Independent Florida Alligator

By ASHLYN POWELL, Alligator Contributing Writer UF researchers have made a breakthrough in gene therapy, which they hope will help reduce Parkinson's ...


Gene therapy could possibly assist jump-start ailing heart

HealthJockey.com

Scientists from the Universities of Michigan and Minnesota have revealed that gene therapy could possibly be used in order to improve an ailing heart's ...



Source - Medical News Today:


No Such Thing As 'Junk RNA,' Say Pitt Researchers

Tiny strands of RNA previously dismissed as cellular junk are actually very stable molecules that may play significant roles in cellular processes, according to researchers at the University of Pittsburgh School of Medicine and the University of Pittsburgh Cancer Institute (UPCI). Thefindings, published in the online version of the Journal of Virology, represent the first examination of very small RNA products termed unusually small RNAs (usRNAs). Further study of these usRNAs, which are present in the thousands but until now have been neglected, could lead to new types of biomarkers for diagnosis and prognosis, and new therapeutic targets. In recent years, scientists have recognized the importance of small RNAs that generally contain more than 20 molecular units called nucleotides, said senior author Bino John, Ph.D., assistant professor, Department of Computational Biology, Pitt School of Medicine.

http://www.medicalnewstoday.com/articles/167351.php


How Stem Cells Yield Functional Regions In 'Gray Matter'

The cerebral cortex, the largest and most complex component of the brain, is unique to mammals and alone has evolved human specializations. Although at first all stem cells in charge of building the cerebral cortex - the outermost layer of neurons commonly referred to as gray matter - are created equal, soon they irrevocably commit to forming specific cortical regions. But how the stem cells' destiny is determined has remained an open question. In the Oct. 11 advance online edition of Nature Neuroscience, scientists at the Salk Institute for Biological Studies report that they have identified the first genetic mechanism that determines the regional identity of progenitors tasked with generating the cerebral cortex. Their discovery reveals a critical period during which a LIM homeodomain transcription factor known as Lhx2 decides over the progenitors' regional destiny: Once the window of opportunity closes, their fate is sealed.

http://www.medicalnewstoday.com/articles/167346.php



New Legislation Would Codify NIH Guidelines On Stem Cell Research, Funding, Washington Post Editorial Says

An upcoming bill -- the Stem Cell Research Enhancement Act of 2009, by Rep. Diana DeGette (D-Colo.) -- would codify President Obama's executive order "permitting federal funding of such research within guidelines established by the NIH and would require that they be reviewed periodically," a Washington Post editorial states. According to the Post , the NIH guidelines issued last summer for such research "successfully navigated a minefield of ethical and moral questions," the editorial adds. The editorial says Obama's executive order overturned one issued by President George W. Bush in 2001 that "allowed federal funding only for those stem cell lines already developed," which scientists "ultimately found" were "too few" and of "limited" use. DeGette's bill would allow couples to donate surplus embryos for research, "as long as they are fully informed of their choices and not compensated" for the embryos, according to the editorial. The Post states that the NIH guidelines "give donors the ability to change their minds 'until the embryos were actually used.'" A panel of NIH scientists and ethicists will examine the procedures and records for stem cells lines developed on or before July 7 in the U.S. and abroad to determine "whether the lines were derived with voluntary informed consent from donors and in a manner consistent with the new rules," according to the editorial.

http://www.medicalnewstoday.com/articles/167278.php


Scientists Solve 100-year Cancer Puzzle

A rare case of a mother and her infant developing the exact same cancer has allowed an international team of researchers to solve a puzzle that has perplexed scientists and clinicians for a century. Scientists at The Institute of Cancer Research (ICR) and colleagues in Japan, with funding from Leukaemia Research, investigated a situation in which leukaemic cells appeared to

have defied accepted theories of biology and spread through the womb from a Japanese woman to her daughter.

http://www.medicalnewstoday.com/articles/167184.php



Source - MIT's Technology Review:


Flu Vaccines Hit a Wall

http://www.technologyreview.com/biomedicine/23665/


Seamlessly Melding Man and Machine

http://www.technologyreview.com/biomedicine/23714/